History
  • No items yet
midpage
941 F.3d 1320
Fed. Cir.
2019
Read the full case

Background:

  • Arthrex, Inc. appealed a PTAB final written decision cancelling claims of U.S. Patent No. 9,179,907 after an inter partes review (IPR) conducted by a three-APJ panel.
  • Administrative Patent Judges (APJs) are appointed by the Secretary of Commerce (in consultation with the USPTO Director) under 35 U.S.C. § 6(a); the Director is presidentially appointed and Senate-confirmed.
  • APJs conduct trial‑like proceedings: oversee discovery, hear oral argument, apply evidentiary rules, and issue final written decisions that determine patentability and can result in claim cancellation.
  • Arthrex challenged on appeal that APJs were unconstitutionally appointed under the Appointments Clause because they are principal officers, not inferior officers.
  • The government and appellees argued waiver and defended the current appointment/removal framework and Director oversight as sufficient; the court nevertheless exercised discretion to reach the Appointments Clause claim.
  • The Federal Circuit found the APJs were principal officers, severed the statutory removal protections as applied to APJs, vacated the PTAB decision, and remanded for a new hearing before a properly constituted panel.

Issues:

Issue Plaintiff's Argument Defendant's Argument Held
Waiver Arthrex: claim timely raised on appeal; raising below would be futile because PTAB couldn't remedy constitutional defect Appellees/Govt: Arthrex forfeited by not raising at PTAB; DBC counsels restraint Court exercised discretion and heard the claim; not barred by waiver because PTAB could not have provided relief
Officer status (Officer vs. employee) APJs exercise significant authority (trials, factfinding, final decisions) so are Officers of the United States Govt did not dispute officer status APJs are Officers of the United States
Principal vs. inferior officer APJs issue final agency decisions without meaningful review by presidentially-appointed officers and have limited removal exposure, so are principal officers Govt: Director has supervisory tools (policy, regs, panel designation, Precedential Opinion Panel) and Title 5 removal constraints create control APJs are principal officers because lack of adequate executive review and limited removal power outweigh supervisory tools
Remedy / Severability Arthrex: require remedy (vacate/remand; cure via making APJs removable at will or other fixes) Govt: various remedies (construe Title 5 differently, sever three-member requirement, or sever Title 5 as applied) Court severed application of Title 5 removal protections to APJs (narrowest cure), vacated the PTAB decision, and remanded for a new hearing before a new APJ panel per Lucia

Key Cases Cited

  • Free Enterprise Fund v. Public Co. Accounting Oversight Bd., 561 U.S. 477 (2010) (severance of removal restrictions can cure Appointments Clause defects)
  • Lucia v. SEC, 138 S. Ct. 2044 (2018) (when adjudicator was unconstitutionally appointed, remedy is vacatur and new hearing before properly appointed adjudicator)
  • Freytag v. Commissioner, 501 U.S. 868 (1991) (Appointments Clause challenges may be considered on appeal even if not raised below)
  • Edmond v. United States, 520 U.S. 651 (1997) (framework for distinguishing principal vs. inferior officers—review, supervision, removal)
  • Buckley v. Valeo, 424 U.S. 1 (1976) (Officer of the United States defined by exercise of significant authority under U.S. law)
  • Intercollegiate Broad. Sys. v. Copyright Royalty Bd., 684 F.3d 1332 (D.C. Cir. 2012) (analogous severance of removal limits for Copyright Royalty Judges)
  • Masias v. Sec’y of Health & Human Servs., 634 F.3d 1283 (Fed. Cir. 2011) (special masters held inferior officers where their decisions were subject to review by Article I court)
Read the full case

Case Details

Case Name: Arthrex, Inc. v. Smith & Nephew, Inc.
Court Name: Court of Appeals for the Federal Circuit
Date Published: Oct 31, 2019
Citations: 941 F.3d 1320; 18-2140
Docket Number: 18-2140
Court Abbreviation: Fed. Cir.
Log In
    Arthrex, Inc. v. Smith & Nephew, Inc., 941 F.3d 1320